Timothy Miller, MD, PhD, the David Clayson Professor of Neurology at Washington University School of Medicine in St. Louis, and a group of his colleagues have received the inaugural Healey Center International Prize for innovation in amyotrophic lateral sclerosis (ALS) research from the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital.
The prize celebrates excellence in research by an individual or team that has made exceptional discoveries leading to a transformative advance in therapy development in ALS, also known as Lou Gehrig’s disease.
The prize was awarded to Miller and colleagues for their discovery and development of a new way to treat a genetic form of ALS caused by a mutation in the gene SOD1. Read more on the School of Medicine site.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.